GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ArcticZymes Technologies ASA (FRA:B4V) » Definitions » Net Income Including Noncontrolling Interests

ArcticZymes Technologies ASA (FRA:B4V) Net Income Including Noncontrolling Interests : €1.52 Mil (TTM As of Mar. 2024)


View and export this data going back to . Start your Free Trial

What is ArcticZymes Technologies ASA Net Income Including Noncontrolling Interests?

Net Income Including Noncontrolling Interests is the net income of the group after the adjustment of all expenses and benefit. It includes the net income (loss) attributable to noncontrolling and redeemable noncontrolling interests and the net income (loss) attributable to the company.

ArcticZymes Technologies ASA's Net Income Including Noncontrolling Interests for the three months ended in Mar. 2024 was €0.28 Mil. Its Net Income Including Noncontrolling Interests for the trailing twelve months (TTM) ended in Mar. 2024 was €1.52 Mil.


ArcticZymes Technologies ASA Net Income Including Noncontrolling Interests Historical Data

The historical data trend for ArcticZymes Technologies ASA's Net Income Including Noncontrolling Interests can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ArcticZymes Technologies ASA Net Income Including Noncontrolling Interests Chart

ArcticZymes Technologies ASA Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net Income Including Noncontrolling Interests
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.59 8.02 4.57 3.14 1.69

ArcticZymes Technologies ASA Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Net Income Including Noncontrolling Interests Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.45 0.48 0.53 0.24 0.28

ArcticZymes Technologies ASA Net Income Including Noncontrolling Interests Calculation

Net Income Including Noncontrolling Interests is the net income of the group after the adjustment of all expenses and benefit. It includes the net income (loss) attributable to noncontrolling and redeemable noncontrolling interests and the net income (loss) attributable to the company.

Net Income Including Noncontrolling Interests for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €1.52 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


ArcticZymes Technologies ASA Net Income Including Noncontrolling Interests Related Terms

Thank you for viewing the detailed overview of ArcticZymes Technologies ASA's Net Income Including Noncontrolling Interests provided by GuruFocus.com. Please click on the following links to see related term pages.


ArcticZymes Technologies ASA (FRA:B4V) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ArcticZymes Technologies ASA (FRA:B4V) » Definitions » Net Income Including Noncontrolling Interests
Traded in Other Exchanges
Address
Sykehusveien 23, Tromso, NOR, N-9294
ArcticZymes Technologies ASA is a biotechnology company. The company is engaged in developing, producing, and marketing immune-modulating beta-glucans and novel recombinant enzymes. The company's products include Woulgan wound gel, Feed Ingredient (M-Glucan), Nutraceuticals (M-Gard), Recombinant enzymes, and others. The company reports in two operating segments that are Enzymes and Corporate. Geographically, it derives a majority of revenue from the USA.

ArcticZymes Technologies ASA (FRA:B4V) Headlines

No Headlines